drugset

drugset / Trial / NCT07225374

Cisplatin-Based Chemotherapy Followed by Maintenance Avelumab in UTUC

NCT07225374 ↗

Phase 2 Recruiting 48 enrolled Samsung Medical Center

NaSingle-groupOpen-labelTreatment

Summary

A Prospective Phase II Study of Adjuvant Cisplatin-Based Chemotherapy followed by Maintenance Avelumab in Upper Tract Urothelial Carcinoma

Timeline

Start: 2025-09-16
Primary completion: 2026-07-01
Completion: 2029-07-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Avelumab	Monoclonal antibody	10 mg/kg	Other

Indications